Saturday, November 19, 2011
Print Current Day:
|
|
SESSION 39 SCHEDULE | |
Saturday
SESSION 39:
NEW DEVELOPMENTS IN ABDOMINAL ANEURYSMS AND THEIR TREATMENT: LAPAROSCOPY (5-MINUTE TALKS)
Moderators:Wesley S. Moore, MD / Roger M. Greenhalgh, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
6:40 AM - 6:45 AM | Health Care Rationing: Should Patients >80 With A Ruptured AAA Be Offered Open Repair Or EVAR: Is It Clinically And Cost Effective: Based On An Analysis Of 250 Patients |
Presenter(s):Florian Dick, MD | |
6:46 AM - 6:51 AM | Do Newer Devices Facilitate EVAR For Ruptured AAAs: What Percent Can Be Done Endovascularly |
Presenter(s):Carlo Setacci, MD | |
6:52 AM - 6:57 AM | Predictors Of AAA Sac Enlargement After EVAR: Expanding Indications Lead To Sac Growth And Failure In A Greater Percentage Of Patients: A Note Of Caution |
Presenter(s):Andres Schanzer, MD | |
6:58 AM - 7:03 AM | Overall Results With EVAR Show There Is No Cause For Alarm With The Procedure |
Presenter(s):Richard P. Cambria, MD | |
7:04 AM - 7:09 AM | Simplified Endowedge Technique Without Axillary/Brachial Access For Short AAA Necks Using The C3 Redeployable Excluder System |
Presenter(s):David J. Minion, MD | |
7:10 AM - 7:15 AM | Duplex Ultrasound Surveillance To Detect Important EVAR Limb Stenosis Or Kinking And Permit Prophylactic Intervention To Prevent Occlusion |
Presenter(s):Keith D. Calligaro, MD | |
7:16 AM - 7:21 AM | A New Concept In The Pathogenesis Of Endotension And Its Implications For Management |
Presenter(s):Timur P. Sarac, MD | |
7:22 AM - 7:27 AM | Panel Discussion |
Moderator(s): Brian R. Hopkinson, ChM, FRCS / Gregorio A. Sicard, MD | |
7:28 AM - 7:33 AM | Comparison Of Laparoscopic And Open AAA Repair In A Case Matched Trial: Advantages And Limitations Of Laparoscopic Repair |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
7:34 AM - 7:39 AM | New From The U.K. EVAR Trial: Preop Quantitation Of Calcium Neck Thrombus And Angulation And Iliac Tortuosity Allows Prediction Of Adverse Outcomes From EVAR |
Presenter(s):Thomas R. Wyss, MD / Roger M. Greenhalgh, MD | |
7:40 AM - 7:45 AM | DEBATE: We Still Need Randomized Controlled (RC) Trials Of EVAR vs. Open Repair (OR) With Ruptured AAAs: What Will The Dutch And French RC Trials Tell Us |
Presenter(s):Willem Wisselink, MD | |
7:46 AM - 7:51 AM | DEBATE: We Don’t Need Randomized Controlled Trials: EVAR Is Better Than OR For Both Early And Late Survival Outcomes |
Presenter(s):Dieter O. Mayer, MD | |
7:52 AM - 7:57 AM | Is Open Repair Of AAAs Making A Comeback: Should It Be |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
7:58 AM - 8:03 AM | DEBATE: Long-Term Survival Results After EVAR Justify Preferential Use Of EVAR In Good Risk Young Patients With Good Anatomy |
Presenter(s):Jan D. Blankensteijn, MD | |
8:04 AM - 8:09 AM | DEBATE: Not So - EVAR Is Not Yet Justified In Good Risk Young Patients: There Is No Late Survival Advantage |
Presenter(s):Peter L. Harris, MD, FRCS | |
8:10 AM - 8:16 AM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Saturday
SESSION 40:
NEW DEVELOPMENTS IN TREATMENT OF THE ABDOMINAL AORTA AND ITS BRANCHES
Moderators:K. Wayne Johnston, MD, FRCS / Edward B. Diethrich, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
8:16 AM - 8:21 AM | DEBATE: All Aortoiliac Occlusive Disease Can And Should Be Treated Endovascularly: Including Juxtarenal Occlusions |
Presenter(s):Martin Malina, MD, PhD | |
8:22 AM - 8:27 AM | DEBATE: Not So – The Best Treatment Of Juxtarenal Aortic Occlusion Is And Will Be By Open Surgery |
Presenter(s):Roberto Chiesa, MD | |
8:28 AM - 8:33 AM | The Number Of Aortofemoral Bypasses And Leg Bypasses Is Increasing In Austria And Germany Despite The Use Of Endovascular Treatments By Many Interventional Specialists |
Presenter(s):Afshin Assadian, MD / Hans-Henning Eckstein, MD, PhD | |
8:34 AM - 8:39 AM | Current Treatment Of Aortic Coarctation: Is There A Place For Endovascular Treatment |
Presenter(s):James C. Stanley, MD | |
8:40 AM - 8:45 AM | Endovascular vs. Open Surgical Treatment For Mesenteric Ischemia: A Consensus View |
Presenter(s):Timothy M. Sullivan, MD | |
8:46 AM - 8:51 AM | Endovascular Treatment Of Long (>3 cm) SMA Occlusions Is Feasible And Safe: Tips And Tricks For Making It Work |
Presenter(s):Giancarlo Mansueto, MD | |
8:52 AM - 8:57 AM | Has Endovascular Treatment Improved Outcomes Of Acute Mesenteric Ischemia: Tips And Tricks For Doing It Right |
Presenter(s):Manju Kalra, MBBS | |
8:58 AM - 9:03 AM | Late Outcomes Of Celiac And SMA PTA And Stenting: Should PTA And Stenting Be The First Line Of Therapy |
Presenter(s):Ali F. AbuRahma, MD | |
9:04 AM - 9:09 AM | Midterm Results After Treatment Of Visceral And Peripheral Aneurysms With A Multilayer Uncovered Stent (Cardiatis) |
Presenter(s):Claudio Rabbia, MD, PhD | |
9:10 AM - 9:20 AM | Panel Discussion |
Moderator(s): John J. Ricotta, MD / James C. Stanley, MD | |
9:20 AM - 9:25 AM | Future Of Renal Artery Stenting In View Of The ASTRAL And CORAL Trials |
Presenter(s):Thomas A. Sos, MD | |
9:26 AM - 9:31 AM | Use Of Balloon Expandable Covered Stents: A Better Treatment For Renal In Stent Restenosis |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
9:32 AM - 9:37 AM | Tips And Tricks To Make Renal Chimney Grafts Work With Juxtarenal AAAs And Other Hostile Necks: Will They Take The Place Of Most Fenestrated Grafts |
Presenter(s):Daniele Gasparini, MD | |
9:38 AM - 9:43 AM | Tips And Tricks For Hypogastric Revascularization With Branched Grafts With EVAR: The Bi-branched Graft: A Special Cook Device For Use When The Common Iliacs Are Short And Aneurysmal |
Presenter(s):Stephen W.K. Cheng, MBBS | |
9:44 AM - 9:49 AM | The Sandwich Technique For Hypogastric Revascularization Using Off-The-Shelf Devices: Diagram Of Technique, Advantages And 3-Year Results |
Presenter(s):Armando C. Lobato, MD, PhD | |
9:50 AM - 9:55 AM | Branched Grafts For Hypogastric Revascularization: Are They Durable: When Are They Feasible And When Not |
Presenter(s):Ian Loftus, MD | |
9:56 AM - 10:01 AM | Failure Of Hypogastric Revascularization With EVAR: Is It A Cause Of Concern |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
10:02 AM - 10:07 AM | Do Statins Lead To Decrease AAA Growth And Rupture Potential |
Presenter(s):Janet T. Powell, MD, PhD | |
10:08 AM - 10:21 AM | Panel Discussion/Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Saturday
SESSION 41:
THE FUTURE: ISSUES REGARDING HEALTH CARE, THE GOVERNMENT, INDUSTRY RELATIONSHIPS AND PRACTICE PATTERNS (5-MINUTE TALKS)
Moderators:Michel S. Makaroun, MD / Frank J. Veith, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
10:21 AM - 10:26 AM | What Is Happening With The Effort Of Government And Universities To Separate Industry And Medical Doctors |
Presenter(s):Barry T. Katzen, MD | |
10:27 AM - 10:32 AM | What U.S. Vascular Surgeons Can Do To Survive Under Obamacare |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
10:33 AM - 10:38 AM | What Will Happen To Reimbursement For Vascular Procedures: What Does The Economic Future Look Like |
Presenter(s):Robert M. Zwolak, MD, PhD | |
10:39 AM - 10:44 AM | The Thoracic Aneurysm Repair Hospital Volume Is Associated With Decreased Mortality For Open Repair But Not For TEVAR |
Presenter(s):Richard P. Cambria, MD / Virendra I. Patel, MD | |
10:45 AM - 10:50 AM | What Is The Future Place Of Robotic Vascular Surgery |
Presenter(s):Willem Wisselink, MD | |
10:51 AM - 10:56 AM | Case Specific Simulator Rehearsal Prior To CAS Will Be Best For The Future |
Presenter(s):Karl A. Illig, MD | |
10:57 AM - 11:02 AM | Have Drug Eluting Stents Changed Lower Extremity Practice In Europe And How Will They Do So In The U.S. |
Presenter(s):Dierk Scheinert, MD | |
11:03 AM - 11:08 AM | How Have Drug Eluting Balloons Changed Lower Extremity Practice In Europe And How Will They Do So In The U.S. |
Presenter(s):Gunnar Tepe, MD | |
11:09 AM - 11:14 AM | Computerized System For Simplified Recordkeeping, Op Notes, Billing, Coding And Endovascular Inventory Control |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
11:15 AM - 11:20 AM | How To Beat The Cardiologists At Their Own Game And Maintain A Vascular Surgery Practice: Advice To Vascular Surgeons From Behind The Iron Curtain |
Presenter(s):William A. Gray, MD | |
11:21 AM - 11:26 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Saturday
SESSION 42:
A TRIBUTE TO OUR MILITARY (6-MINUTE TALKS)
Moderators:Charles J. Fox, MD, FACS / Norman M. Rich, MD, FACS, DMCC
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
11:26 AM - 11:32 AM | MEDEVAC Development And Innovative Ground Combat Medical Support To Marines From 2003 To 2011 |
Presenter(s):Stephen F. McCartney, MD, FACS | |
11:33 AM - 11:39 AM | Front Line Military Experience In Afghanistan And Iraq |
Presenter(s):Robert Craig, DO | |
11:40 AM - 11:46 AM | Endovascular Technology For Aortic Control Can Help In The Treatment Of Torso Hemorrhage From Combat Wounds |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
11:47 AM - 11:53 AM | Pearls From The Long-Term Follow-up Of Cases From The Vietnam Vascular Injury Registry |
Presenter(s):Norman M. Rich, MD, FACS, DMCC | |
11:54 AM - 12:00 PM | Vascular Trauma In The Terrorism Era: New Challenges To The Vascular Surgeon |
Presenter(s):Eitan Heldenberg, MD | |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Saturday
SESSION 43:
LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
Moderators:Brian R. Hopkinson, ChM, FRCS / Richard P. Cambria, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
12:00 PM - 12:05 PM | Latest Generation AAA Stent-Grafts Are Being Heralded As Important Advances: Are We Too Quick To Embrace Unproven Technology |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
12:06 PM - 12:11 PM | The Cordis INCRAFT AAA Endograft: A Lower Profile Device: Advantages And Disadvantages |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
12:12 PM - 12:17 PM | Experience With The TriVascular OVATION AAA Endograft: Results Of The Pivotal U.S. And Out Of U.S. Trials With A Unique Lower Profile Device |
Presenter(s):Francisco Valdes, MD / Michael D. Dake, MD | |
12:18 PM - 12:23 PM | Advantages And Benefits Of The New C3 Gore Excluder AAA Graft - Does The Ability To Reposition Make A Difference: The European And U.S. Experience |
Presenter(s):Eric L.G. Verhoeven, MD, PhD / Mark F. Fillinger, MD | |
12:24 PM - 12:29 PM | Clinical Experience With The Endologix (VENTANA) Off-The-Shelf Fenestrated Device For Juxtarenal AAAs: Advantages And Limitations |
Presenter(s):Daniel G. Clair, MD | |
12:30 PM - 12:35 PM | World And U.S. Experience With The Nellix Device For EVAR: A New Concept With Polymer Filled Bags Obliterating The AAA Sac And Maintaining Flow With Stents: Advantages, Limitations And Midterm Results |
Presenter(s):Clifford J. Buckley, MD / Andrew Holden, MBChB / Carlos E. Donayre, MD | |
12:36 PM - 12:41 PM | ANACONDA Fenestrated Endograft For Juxtarenal AAAs: Principles And Clinical Experience |
Presenter(s):Peter M. Bungay, MBChB | |
12:42 PM - 12:47 PM | U.S. Pivotal Trial Results With The ANACONDA Device For EVAR: Advantages And Limitations |
Presenter(s):Christopher J. Kwolek, MD | |
12:48 PM - 12:53 PM | U.S. Pivotal Trial And Other Experience With The AORFIX Device: Advantages And Limitations |
Presenter(s):Mark F. Fillinger, MD | |
12:54 PM - 1:00 PM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Saturday
SESSION 44:
ISSUES RELATED TO MAINTENANCE OF CERTIFICATION, TRAINING, AND SIMULATION (FAST PACED 4-MINUTE TALKS)
Moderators:Anton N. Sidawy, MD, MPH / Ralph G. DePalma, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
1:00 PM - 1:04 PM | Latest Developments In Maintenance Of Certification (MOC) By The Vascular Surgery Board Of The ABS: What Will The Requirements Be |
Presenter(s):Samuel R. Money, MD, MBA | |
1:05 PM - 1:09 PM | How Is The 0 + 5 Vascular Surgery Training Program Coming Along |
Presenter(s):Karl A. Illig, MD | |
1:10 PM - 1:14 PM | Use Of Laparoscopic Skills In Vascular Surgery: Should All Vascular Trainees (Residents/Fellows) Learn Them |
Presenter(s):Joseph S. Giglia, MD | |
1:15 PM - 1:19 PM | DEBATE: Simulation Will Be An Essential Part Of Future Vascular Surgery Training |
Presenter(s):Isabelle van Herzeele, MD, PhD | |
1:20 PM - 1:24 PM | DEBATE: Simulation Is A Waste Of Time: All Training Should Be Patient Based |
Presenter(s):Marc Bosiers, MD | |
1:25 PM - 1:29 PM | Simulators To Teach Open Aortic Surgery: The Pontresina System Works In The U.S. |
Presenter(s):Peter F. Lawrence, MD | |
1:30 PM - 1:34 PM | Pulsatile Simulators For Training In Different Open Vascular Operation: The Latest Pontresina System |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
1:35 PM - 1:39 PM | Role Of Simulators In Vascular Surgical Training: Can They Work To Train For Treating Type II Endoleaks |
Presenter(s):Alan B. Lumsden, MD, FACS | |
1:40 PM - 1:44 PM | Virtual Reality Simulation Training In A Fully Equipped Hybrid Operating Room |
Presenter(s):Lars Lonn, MD, PhD / Torben V. Schroeder, MD, DMSc | |
1:45 PM - 1:49 PM | Upcoming Challenges With Atherectomy, Lasers And Drug Eluting Balloons |
Presenter(s):Nicholas J.W. Cheshire, MD | |
1:50 PM - 1:55 PM | Panel Discussion |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Saturday
SESSION 45:
FDA, ETHICS, HEALTH CARE REFORM AND COSTS, GUIDELINES, STANDARDS, HISTORY, MALPRACTICE ISSUES (5-MINUTE TALKS)
Moderators:Robert M. Zwolak, MD, PhD / Timur P. Sarac, MD
|
|
x | |
PLENARY SESSIONS (SESSIONS 39 - 45) - LOCATION: GRAND BALLROOM, 3RD FLOOR | |
1:55 PM - 2:00 PM | The FDA Is Changing To Encourage Technological Progress, Not Stifle It: The Innovation Pathway And Improvements To The Innovation Ecosystem |
Presenter(s):Dorothy B. Abel, BSBME / Megan Monahan / Jeffrey Shuren, MD, PhD / Jonathan Sackner-Bernstein, MD | |
2:01 PM - 2:06 PM | What Is The FDA Doing To Support Valid Trials Of Devices To Treat Lower Extremity Ischemia |
Presenter(s):Kenneth J. Cavanaugh, Jr., PhD | |
2:07 PM - 2:12 PM | German Guidelines For The Treatment Of Extracranial Carotid Stenosis And Where Do We Stand With SPACE II |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
2:13 PM - 2:18 PM | Why Do Some Centers Not Participate In Randomized Controlled Trials: The Unethical Reasons Are A Dark Side Of Current Medicine: What Is The Solution |
Presenter(s):Emmanuel M. Houdart, MD | |
2:19 PM - 2:24 PM | Some Thoughts On How We Should Reform The Health Care System |
Presenter(s):Thomas J. Fogarty, MD | |
2:25 PM - 2:30 PM | Why Are U.S. Health Care Costs So Out Of Control And What Should Be Done About It |
Presenter(s):Wesley S. Moore, MD / Frank J. Veith, MD | |
2:31 PM - 2:36 PM | Impact Of Socioeconomic Factors On Revascularization And Aortic Therapy: Poor Folks Have Worse Disease And Cost More |
Presenter(s):Michael C. Stoner, MD | |
2:37 PM - 2:42 PM | New Developments In Malpractice Litigation: Are Practice Guidelines Helpful Or Harmful: Is Working For A Hospital Good Or Bad: When Does A Plaintiff’s Attorney Sue |
Presenter(s):O. William Brown, MD, JD | |
2:43 PM - 2:48 PM | Current Status Of VESAP And How It Can Help Vascular Surgeons And Other Specialists |
Presenter(s):Douglas L. Wooster, MD | |
2:49 PM - 3:10 PM | Panel Discussion/Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Saturday
SESSION 46:
MISCELLANEOUS TOPICS RELATED TO VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENT, PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Barry T. Katzen, MD / Dhiraj M. Shah, MD
|
|
x | |
PROGRAM I (SESSIONS 46 - 47) - LOCATION: GRAND BALLROOM EAST, 3RD FLOOR | |
3:10 PM - 3:15 PM | DEBATE: With LDL Cholesterol, The Lower The Better And That Should Be The Aim Of Statin Therapy So Patients Live Longer And Better |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
3:16 PM - 3:21 PM | DEBATE: With LDL Cholesterol, Lowering It Aggressively Just Means More Money For The Doctor And The Pharmaceutical Industry |
Presenter(s):Erich Minar, MD | |
3:22 PM - 3:27 PM | Statins Are Not So Magical In Diabetics With Vascular Inflammation |
Presenter(s):Firas F. Mussa, MD | |
3:28 PM - 3:33 PM | A Single Systolic Blood Pressure Measurement Is Strongly Predictive Of Carotid Stenosis, PAD And AAA Disease: Based On A Study In 3.5 Million Patients: What Does It Mean For Blood Pressure Treatment And Screening |
Presenter(s):Caron B. Rockman, MD | |
3:34 PM - 3:39 PM | Effects Of Supervised Exercise And Angiotensin Receptor Blockers (ARBs) On Progression Of AAA Disease: Results Of The STOP EXERCISE And TEDY Trials |
Presenter(s):Ronald L. Dalman, MD | |
3:40 PM - 3:45 PM | Effect Of The Presence Of A Small AAA On Death And MI Rates: What Should We Do About It: Give More Statins |
Presenter(s):Henrik Sillesen, MD, DMSc | |
3:46 PM - 3:51 PM | Tips And Tricks For Managing Vascular Injuries In Infants And Children |
Presenter(s):J. Leonel Villavicencio, MD | |
3:52 PM - 3:57 PM | Depression And Smoking In Vascular Disease Patients: It Is Important And What Can Be Done About It |
Presenter(s):Jan M.M. Heyligers, MD, PhD / Patrick W.H. Vriens, MD, PhD | |
3:58 PM - 4:03 PM | The Role Of Statin Therapy And Angiotensin Blockade (ACE/ARB) In Patients With 50-79% Carotid Stenosis: They Decrease Risk And Cut Costs |
Presenter(s):Michael C. Stoner, MD | |
4:04 PM - 4:14 PM | Panel Discussion |
Moderator(s): Peter R.F. Bell, MD, FRCS, DSC, KBE / R. Clement Darling III, MD | |
4:14 PM - 4:19 PM | Beta Blockers Before Open AAA Repair And Other Vascular Procedures: They Still Save Lives Despite The POISE Trial Findings |
Presenter(s):Bruce A. Perler, MD, MBA | |
4:20 PM - 4:25 PM | Latest Advances In Statin Treatment And Other Medical Treatments For Patients Undergoing Open And Endovascular Procedures: Optimal Timing And Dosage Of Statins And Beta Blockers Preoperatively |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
4:26 PM - 4:31 PM | DEBATE: Statins Don’t Do Much Good And May Be Harmful |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
4:32 PM - 4:37 PM | DEBATE: That’s Nonsense, Statins Do So Many Good Things For Vascular Patients That They Are Indicated In Everyone With Vascular Risk Factors And Perhaps In Some Without |
Presenter(s):Bruce A. Perler, MD, MBA | |
4:38 PM - 4:43 PM | Ultrasound Guidance Can Decrease The Incidence Of Complication With All Closure Devices |
Presenter(s):Fabrizio Fanelli, MD | |
4:44 PM - 4:49 PM | Long-Term Results Of VAC On Vessel (VoV) Treatment Of Prosthetic Arterial Graft Infections Show It Is A Good Technique |
Presenter(s):Dieter O. Mayer, MD | |
4:50 PM - 4:55 PM | Modern Management Of Primary And Secondary Aorto-Esophageal And Aorto-Bronchial Fistulas: Survival Is Possible With Combined Endo (TEVAR) And Open Procedures |
Presenter(s):Roberto Chiesa, MD | |
4:56 PM - 5:03 PM | Panel Discussion |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Saturday
SESSION 47:
UPDATES, NEW TECHNIQUES, NEW CONCEPTS (5-MINUTE TALKS)
Moderators:Ramon Berguer, MD, PhD / Mark A. Adelman, MD
|
|
x | |
PROGRAM I (SESSIONS 46 - 47) - LOCATION: GRAND BALLROOM EAST, 3RD FLOOR | |
5:04 PM - 5:09 PM | Treatment Of Large Pelvic A-V Malformations With Embolization And Sclerotherapy: Technique, Precautions And Results |
Presenter(s):Young Wook Kim, MD | |
5:10 PM - 5:15 PM | Techniques For Simplified, Safe Endovascular Management Of Iatrogenic Subclavian Artery Injuries Including Placement Of A Large Dialysis Catheter |
Presenter(s):Neal S. Cayne, MD | |
5:16 PM - 5:21 PM | In Patients With CLI, When Adequate Autologous Vein Is Not Available And There Are No Good Endovascular Options, A PTFE Bypass To A Tibial Or Perineal Artery Can Yield Acceptable Patency And Limb Salvage Results |
Presenter(s):Nicholas J. Gargiulo III, MD / Frank J. Veith, MD | |
5:22 PM - 5:27 PM | Early TIPS Procedure With A VIATOR Stent-Graft Is Effective Treatment For Portal Hypertension With Symptomatic Ascites |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
5:28 PM - 5:33 PM | The Altura Endograft: A Simple New Ultra Low Profile AAA Endograft |
Presenter(s):Albrecht H. Kramer, MD | |
5:34 PM - 5:39 PM | Percentage Of Traumatic Aortic Transections With Aortic Diameters <22 mm: What Is New In TEVAR For Traumatic Aortic Injuries |
Presenter(s):Mark A. Farber, MD | |
5:40 PM - 5:45 PM | Cost And Outcome Analyses Of Endo vs. Open Repair For Blunt Traumatic Aortic Injuries: Which Ones Should Not Be Treated Invasively |
Presenter(s):Ali Azizzadeh, MD / Hazim J. Safi, MD | |
5:46 PM - 5:51 PM | What Is Controlled Reperfusion In Patients With Acute Limb Ischemia: Technique And How It Helps |
Presenter(s):Florian Dick, MD | |
5:52 PM - 5:57 PM | Contemporary Techniques And Results With Endovascular Treatment Of Acute Limb Ischemia |
Presenter(s):Vikram S. Kashyap, MD | |
5:58 PM - 6:03 PM | Embolic Protection In Lower Extremity Interventions . . . Necessary, Or An Expensive Waste Time? |
Presenter(s):Mark H. Wholey, MD | |
6:04 PM - 6:15 PM | Panel Discussion |
END OF SESSION 47 | |
SESSION 48 SCHEDULE | |
Saturday
SESSION 48:
UPDATES, NEW TECHNOLOGY, NEW CONCEPTS, NEW HORIZONS (5-MINUTE TALKS)
Moderators:Michael B. Silva, Jr., MD / Jacques Busquet, MD
|
|
x | |
PROGRAM J (SESSIONS 48 - 49) - LOCATION: GRAND BALLROOM WEST, 3RD FLOOR | |
3:10 PM - 3:15 PM | Early Clinical Experience With The Low Profile AAA Stent-Graft (INCRAFT) From Cordis |
Presenter(s):Enrico M. Marone, MD / Dierk Scheinert, MD | |
3:16 PM - 3:21 PM | Revitalization Of Brachytherapy With Rh188 To Prevent Intimal Hyperplasia And Restenosis |
Presenter(s):Klaus D. Mathias, MD | |
3:22 PM - 3:27 PM | Highly Selective Algorithm For Surgical Treatment Of Neurogenic Thoracic Outlet Syndrome |
Presenter(s):Jason T. Lee, MD | |
3:28 PM - 3:33 PM | Flow Reversal Techniques Are The Best Protection Against Strokes During CAS: What About Strokes Before Or After Protection Is In |
Presenter(s):Claudio J. Schonholz, MD | |
3:34 PM - 3:39 PM | Late Results At 11 Years With The Gore Excluder AAA Device For EVAR: Is It Durable |
Presenter(s):Arno von Ristow, MD | |
3:40 PM - 3:45 PM | How Well Do Stem Cells Work For CLI: What Is The Best Source For These Cells |
Presenter(s):Alan Dardik, MD, PhD | |
3:46 PM - 3:51 PM | Intraoperative Ultrasound To Detect Endoleaks Before Sheath Removal To Facilitate Treatment |
Presenter(s):Ramon L. Varcoe, MD | |
3:52 PM - 3:57 PM | Optimal And Safe Treatment Of Carotid Aneurysms: It Is Not So Easy |
Presenter(s):Frans L. Moll, MD, PhD | |
3:58 PM - 4:03 PM | Checklist For Optimal Diabetic Foot Care |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
4:04 PM - 4:10 PM | Panel Discussion |
Moderator(s): Dhiraj M. Shah, MD / Herbert Dardik, MD | |
4:10 PM - 4:15 PM | Randomized Controlled Prospective Trial Comparing Percutaneous EVAR With Standard EVAR Through Open Femoral Exposures Using Powerlink Grafts: The PEVAR Trial |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
4:16 PM - 4:21 PM | How To Deal With Complex Suboptimal Aortic Necks And Still Perform EVAR Using Standard Off-The-Shelf Current Grafts |
Presenter(s):Luis A. Sanchez, MD | |
4:22 PM - 2:27 PM | Tips And Tricks For Open Conversion After Failed EVAR: How To Make It Safer And Easier |
Presenter(s):Christos D. Liapis, MD | |
4:28 PM - 4:33 PM | Renal Insufficiency Does Not Preclude Successful Endovascular Treatment For CLI: How To Do It Safely |
Presenter(s):Iris Baumgartner, MD | |
4:34 PM - 4:39 PM | Preliminary Results Of The ADSORB Trial Comparing TEVAR For Uncomplicated Type B Aortic Dissections With Medical Treatment |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
4:40 PM - 4:45 PM | Exercise And Best Medical Treatment Is Better Than Invasive Treatments For Most Patients With Intermittent Claudication |
Presenter(s):Henrik Sillesen, MD, DMSc | |
4:46 PM - 4:51 PM | The Level Of The Upper Attachment Zone Of Branched And Fenestrated Grafts For Pararenal And TAAAs Correlates With Morbidity And Mortality: A New Classification System Based On This |
Presenter(s):Krassi Ivancev, MD, PhD | |
4:52 PM - 4:57 PM | Axillary Technique For TEVAR When Access From Below Is Impossible |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
4:58 PM - 5:03 PM | Silver Impregnated Dacron Graft Lowers Graft Infection Rates In High Risk Patients: A Multicenter Experience |
Presenter(s):Max Zegelman, MD, PhD | |
5:04 PM - 5:10 PM | Panel Discussion |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Saturday
SESSION 49:
NEW CONCEPTS, UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
Moderators:Nicholas J. Morrissey, MD
|
|
x | |
PROGRAM J (SESSIONS 48 - 49) - LOCATION: GRAND BALLROOM WEST, 3RD FLOOR | |
5:10 PM - 5:15 PM | Progress In Techniques For In Situ Fenestration To Treat Aortic Arch Lesions Endovascularly: Can Cerebral Perfusion Systems Be Avoided |
Presenter(s):Furuzan Numan, MD | |
5:16 PM - 5:21 PM | Endovascular Repair Of Arch Lesions With In Situ Fenestration: Techniques For Maintaining Cerebral Perfusion And Clinical Experience |
Presenter(s):Bjõrn Sonesson, MD, PhD | |
5:22 PM - 5:27 PM | In Situ Fenestration In The Aortic Arch Is Associated With More Problems Than Success |
Presenter(s):Ralf R. Kolvenbach, MD | |
5:28 PM - 5:33 PM | In Situ Laser Fenestration To Facilitate Revascularization Of Aortic Arch Branches |
Presenter(s):Jean M. Panneton, MD | |
5:34 PM - 5:39 PM | Endovascular Treatment Of Aberrant Subclavian Pathologies |
Presenter(s):Venkatesh G. Ramaiah, MD | |
5:40 PM - 5:45 PM | Results Of A Multicenter Japanese Trial With The NAJLETA Fenestrated Endograft For Aortic Arch Aneurysms |
Presenter(s):Yoshihiko Yokoi, MD / Hiroshi Shigematsu, MD, PhD | |
5:46 PM - 5:51 PM | DEBATE: Open Stents Are Best For The Treatment Of Aortic Coarctation And Recoarctation: Reasons Why And Late Results |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
5:52 PM - 5:57 PM | DEBATE: Balloon Expandable Covered Stents (Advanta V12 From Atrium) Are Best For Treating Coarctation And Recoarctation And Why |
Presenter(s):Elchanan Bruckheimer, MBBS | |
5:58 PM - 6:03 PM | Endovascular Options With Current Off-The-Shelf Technology Using ASD And PDA Devices For Some Ascending Aortic Lesions: Techniques And Limitations |
Presenter(s):Grayson H. Wheatley, MD | |
6:04 PM - 6:09 PM | Up To 6 Years Follow-up Of >100 Chimney Grafts In Various Positions: Are They Durable And How To Make Them Work Safely: Precautions And Limitations |
Presenter(s):Thomas Larzon, MD | |
6:10 PM - 6:15 PM | Panel Discussion |
END OF SESSION 49 |